InvestorsHub Logo
Followers 2
Posts 436
Boards Moderated 0
Alias Born 01/14/2014

Re: None

Friday, 02/23/2018 5:42:17 PM

Friday, February 23, 2018 5:42:17 PM

Post# of 807
So in Haemophilia Lenti should be better than AAV as Lenti maintains it`s expression while the Liver is growing. AAV expresses to a small degree and over time drops off.

All extremely promising. If we can produce the best in class Haemophilia gene therapy, big market.

DLBCL and 2nd Car T, Prosavin etc. Happy days indeed.

HTTP://www.oxfordbiomedica.co.uk/system/files/corporate-presentations/BIVV%20Annoucement%20AnalystPresentation.pdf

There's also a webcast to go with it:
HTTP://www.oxfordbiomedica.co.uk/system/files/webcasts-and-audios/Conf%20call%20150218.mp3